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The effect of intravenously administered deslanoside (Cedilanid) was studied in 24 patients with chronic bronchitis at rest and during exercise. No changes in ventilation, blood gases, and oxygen consumption were observed. In the patients without right heart failure, deslanoside induced a slight reduction in cardiac output, right ventricular end-diastolic and pulmonary arterial wedge pressures, and increase of systemic and pulmonary vascular resistances. The effect of deslanoside was different in the patients with right heart failure: an increase of cardiac output, stroke volume, right and left ventricular stroke work and stroke power, and a more pronounced decrease of R V end-diastolic and pulmonary arterial wedge pressures were observed, with no changes in vascular resistances. We failed to find a significant improvement in cardiac performance after deslanoside during exercise. The effect of deslanoside does not seem to be related to arterial hypoxaemia or hypercapnic acidosis at rest.
The effect of digitalis glucosides has been studied by different authors (Ferrer and Berglund, Widimsky, and Malmberg, I963) . Particular attention has been drawn to the changes in pulmonary arterial and right ventricular pressures, but pulmonary arterial wedge or left heart pressures have been measured only occasionally. Therefore, we have little information about the changes of pulmonary vascular resistance in acute digitalization. We know only one paper (Berglund et al., I963) which deals with the effect of digitalis in exercising patients.
We tried to study the effect of acute digitalization in a group of patients with chronic bronchitis sufficiently large for statistical analysis.
Patients and examination procedure
The study was made in 24 patients with chronic bronchitis, the diagnosis being made on the basis of a positive history of chronic productive cough. All the patients were of a physical and mental state to understand the nature and full circumstances of the investigation, and all of them assented to take part in the study, though they realized that it was not expected to be of direct advantage to themselves. When the diastolic systemic pressure was above go mmHg, the patient was omitted from the study.
The patients were divided into the following groups: Group i includes 9 patients without any history of cardiac failure, Group 2 includes 6 patients with a positive history of cardiac failure from 4 weeks to 2 years before the study, and Group 3 includes 9 patients with signs of right heart failure (leg oedema, liver congestion) at the time of catheterization. No patients had clinical or laboratory signs of tricuspid insufficiency.
Catheterizations (Widimsky, Berglund, and Malmberg, I963) .
Results

Differences between groups at rest
The results are summarized in Mean pulmonary arterial wedge 9 9 ± 2-7 I3-6±2-6 13-2 +2-6 P <0o02 P < 0-02 NS pressure (mmHg)
All values are given as a mean ± I symbols see footnote to (Castaing, I955) . However, evaluation is difficult because some patients were simultaneously given other treatment for respiratory insufficiency.
The acute effect of digitalis glycosides in healthy subjects and in cardiac patients without any history of cardiac failure is usually considered as minimal: no changes (Dresdale et al., I959; Goodyer, rick, and Huvos, I960) or a slight decrease (Williams, Zohman, and Ratner, I958) Berglund et al. (I963) in the patients with chronic bronchitis without chronic heart failure. Nevertheless, it was shown (Braunwald, Ross, and Sonnenblick, I967) that acute digitalization also improves the contractile state of the nonfailing heart. It corroborates our results for compensated patients where a slight but significant decrease in end-diastolic pressure was found.
More pronounced is the effect of deslanoside in patients suffering from chronic heart failure. All our cases showed a significant improvement of cardiac function (increased stroke volume associated with a decrease of RV end-diastolic pressure). Some previous papers conclude that, generally, the effect of digitalis glycosides in chronic cor pulmonale is minimal (Ferrer and Harvey, I959; Berglund et al., I963) . This impression may be obtained by an observation that in right heart failure complicating primordial disease of the left heart, the increase in stroke volume and a reduction in end-diastolic pressure are more pronounced than in cor pulmonale, and that they are accompanied by a reduction of pulmonary arterial pressure (Ferrer, Conroy, and (Jezek and Herles, I969) . Nevertheless, there exists a significant correlation between the changes in pulmonary vascular resistance and left ventricular stroke work in our patients (r = -o-438, P < o0o5), indicating a possible relation between the improvement in left ventricular function and the behaviour of pulmonary vascular resistance.
A shortening of the pre-ejection period may be considered as a sign of the positive inotropic action of deslanoside. This period was slightly prolonged in decompensated patients in whom also the effect of deslanoside is more pronounced. It corresponds to our previous results (Jezek, I963; Jezek, Daum, and Serf, I964) .
Possible negative influence of hypoxaemia or hypercapnic acidosis on the effect of digitalis in chronic bronchitis was discussed by Berglund et al., I963. Recently, Donlon and Yu (I969) showed in an acute experiment that the cardiovascular response of hypoxic myocardium to strophanthin, though significant, is lower than in normal oxygen conditions. In our study, SaO2 before deslanoside at rest varied from 70 to 96 per cent in compensated patients and from 65 to 95 per cent in the cases with chronic heart failure; Paco2 was from 31 to 68 mmHg and from 43 to 77 mmHg, respectively.
Despite this large scale, we failed to find any relation between the values of blood gases and the haemodynamic changes after deslanoside.
Our results indicate that, despite unchanged pulmonary arterial pressure and variable changes of pulmonary vascular resistance, treatment with deslanoside represents an important improvement in cardiac function for patients with chronic bronchitis and chronic heart failure.
